Methods Of Treating Bacterial Infections
Patent No. EP3565551 (titled "Methods Of Treating Bacterial Infections") was filed by Melinta Therapeutics on Jan 8, 2018. The application was issued on Mar 20, 2024.
Patent Summary
Combination therapy of vaborbactam and meropenem for treating urinary tract infections (UTIs) and acute pyelonephritis (AP) in patients with severe comorbidities. The combination provides enhanced efficacy against carbapenem-resistant Enterobacteriaceae (CRE) pathogens, particularly in patients with high-risk profiles such as those with SIRS, severe renal impairment, or a Charlson comorbidity score ≥3. The combination achieves superior clinical outcomes compared to standard meropenem-vaborbactam or piperacillin-tazobactam combinations.
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
EP3565551
- Application Number
- EP18735813A
- Filing Date
- Jan 8, 2018
- Status
- Granted And Under Opposition
- Feb 16, 2024
- Publication Date
- Mar 20, 2024
- External Links
- Slate, Register , Google Patents